Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
131,900
Employees131,900
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
131,900
Employees131,900

JNJ Key Statistics

Market cap
347.85B
Market cap347.85B
Price-Earnings ratio
26.67
Price-Earnings ratio26.67
Dividend yield
3.23%
Dividend yield3.23%
Average volume
7.75M
Average volume7.75M
High today
$145.30
High today$145.30
Low today
$145.00
Low today$145.00
Open price
$145.00
Open price$145.00
Volume
6.93K
Volume6.93K
52 Week high
$175.97
52 Week high$175.97
52 Week low
$143.39
52 Week low$143.39

JNJ News

Yahoo Finance 14h
Why Johnson & Johnson Stock Got Tossed by the Market Today - Yahoo Finance

The latest earnings season has begun, and the latest quarterly results from some of our economy's largest companies are starting to come in. Tuesday morning, i...

Why Johnson & Johnson Stock Got Tossed by the Market Today - Yahoo Finance
Yahoo Finance 15h
J&J CFO: We've 'beefed up' cardiovascular medical devices in hopes of reviving our medtech business - Yahoo Finance

Johnson & Johnson (JNJ) is looking at ways to continue what it sees as a strong opportunity in the medical devices business — historically a slow growth area fo...

J&J CFO: We've 'beefed up' cardiovascular medical devices in hopes of reviving our medtech business - Yahoo Finance
CNBC 19h
Stocks on the move: UnitedHealth and Johnson & Johnson - CNBC

In this video Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email Stocks on the move: UnitedHealth a...

Stocks on the move: UnitedHealth and Johnson & Johnson - CNBC

Analyst ratings

61%

of 23 ratings
Buy
39.1%
Hold
60.9%
Sell
0%

More JNJ News

CNBC 20h
Stocks making the biggest moves midday: UnitedHealth, SolarEdge, Bank of America, Tesla and more - CNBC

Check out the companies making headlines in midday trading. UnitedHealth — Shares climbed more than 6%, single-handedly pushing the Dow Jones Industrial Average...

Stocks making the biggest moves midday: UnitedHealth, SolarEdge, Bank of America, Tesla and more - CNBC
Quartz 20h
Johnson & Johnson's bet on heart devices boosted sales — but it still missed analysts' expectations

Johnson & Johnson’s recent investments in medical devices helped boost sales, but the company’s total revenue in the first quarter of the year failed to beat Wa...

Johnson & Johnson's bet on heart devices boosted sales — but it still missed analysts' expectations
Benzinga 20h
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff

Loading... Loading... On Tuesday, Johnson & Johnson JNJ delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its me...

Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
Bloomberg 21h
J&J CFO on Q1 Earnings, Forecast and Product Pipeline

In this article: Johnson & Johnson CFO Joseph Wolk discusses the company's first-quarter earnings, forecast and product pipeline on Bloomberg Television. Johns...

J&J CFO on Q1 Earnings, Forecast and Product Pipeline
Yahoo Finance 22h
Johnson & Johnson reports mixed Q1 earnings, narrows guidance

Johnson & Johnson (JNJ) reported a mixed bag of first quarter results, missing revenue estimates but beating on the bottom line. The company's revenue came in a...

Johnson & Johnson reports mixed Q1 earnings, narrows guidance
Benzinga 23h
Johnson & Johnson Q1 Earnings Tops Wall Street Estimates On Strong Medical Devices Sales, Boosts Annual Outlook

Loading... Loading... On Tuesday, Johnson & Johnson JNJ reported first-quarter adjusted EPS of $2.71, up 12.4% year over year, beating the consensus of $2.64....

Johnson & Johnson Q1 Earnings Tops Wall Street Estimates On Strong Medical Devices Sales, Boosts Annual Outlook
Investor's Business Daily 23h
Bellwether Health Giant J&J Beats Earnings Calls, But Shares Dip On Light Sales

Early Tuesday, Johnson & Johnson (JNJ) reported adjusted earnings of $2.71 per share on $21.38 billion in first-quarter sales. Johnson & Johnson stock dipped a...

Bellwether Health Giant J&J Beats Earnings Calls, But Shares Dip On Light Sales
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.